As director of Pew's prescription drug abuse project, Reilly works on federal and state initiatives to reduce the health and economic consequences of prescription drug abuse.
Prior to joining Pew, Reilly worked on issues related to the safety and quality of medication use for the American Society of Health-System Pharmacists in Bethesda, Maryland. Areas of focus included the development of clinical policy, dissemination of best practices to improve patient outcomes, and coordination of initiatives aimed at ensuring the availability and integrity of drug products. In this role, she coordinated the society’s work in support of rescheduling hydrocodone combination products from Schedule III to Schedule II to improve the safe and appropriate use of those therapies. In addition, she led development of policy that called on clinicians to increase efforts to combat prescription drug abuse while also ensuring patient access to needed pain therapies.
Reilly received her bachelor’s degree in pharmacy from Temple University in Philadelphia, Pennsylvania. She is currently enrolled in the master’s program in health and medical policy at George Mason University.
On Feb. 1, The Pew Charitable Trusts submitted a letter to Michael Botticelli, director of the White House Office of National Drug Control Policy, offering recommendations to strengthen the 2016 National Drug Control Strategy. Read More
On Jan. 21, The Pew Charitable Trusts sent a letter to Senators Lamar Alexander (R-TN) and Patty Murray (D-WA) expressing support for the National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. Read More
One of the first priorities that President Barack Obama highlighted in last night’s State of the Union speech was bipartisan cooperation to address prescription drug abuse. It was a welcome signal that the growing epidemic of drug abuse and overdose deaths can bring Republicans and Democrats together when action is needed; this can’t come too soon. Read More